SigmaStory Logo
  • Creator Economy
    • Content Creators
    • Influencer Life
    • Startups
  • Social Media
  • News
  • Entertainment
    • Web Series
    • OTT
  • Pop Culture
    • Memes
    • Podcast
SigmaStorySigmaStory
  • Creator Economy
    • Content Creators
    • Influencer Life
    • Content Creation
  • Social Media
  • News
  • Entertainment
    • Web Series
    • OTT
  • Pop Culture
    • Memes
    • Podcast
  • Tech
  • Startups
  • About Us
  • Privacy Policy
  • Disclaimer
  • Contact Us
Pop Culture

Greg Doucette Clarifies Stance on GLP-1 Medications and “Natural” Status

Pro fitness coach Greg Doucette addresses the controversy surrounding GLP-1 medications like Ozempic, debating their status in natural bodybuilding circles.

Harshit Choudhary
ByHarshit Choudhary
Harshit is a content writer with an interest in the digital economy. He writes about breakthroughs and trending stories in the creator world.
Follow:
May 7, 2026 Google Preferred Source
Fitness Influencer Greg Doucette Addresses "Fake Natty" Claims in GLP-1 Debate

Popular fitness personality and professional bodybuilding coach Greg Doucette addressed the growing controversy surrounding the use of weight-loss medications in the fitness community during a recent video.

Doucette clarified his previous statements regarding whether users of glucagon-like peptide-1 (GLP-1) receptor agonists, medications like Ozempic or Tirzepatide, can still be considered “natural” athletes.

The debate centers on whether these drugs, which significantly reduce appetite and promote weight loss, constitute a form of cheating in a community that prides itself on drug-free physical transformation.

Doucette, a Canadian IFBB Pro and prominent YouTube creator with millions of subscribers, explained that his assessment of “natural” status often follows the guidelines set by the World Anti-Doping Agency (WADA).

As the primary international body responsible for monitoring doping in the Olympics and other major sports, WADA does not currently list GLP-1 medications on its prohibited list.

Doucette argued that since these substances do not directly build muscle or enhance physical performance (the primary goal of performance-enhancing drugs), they do not technically violate the broadest definitions of natural athleticism.

The creator acknowledged that more niche organizations, such as the World Natural Bodybuilding Federation (WNBF), have recently implemented stricter rules that specifically ban GLP-1 use for their competitors.

Doucette admitted he made a mistake by previously generalizing that all GLP-1 users are natural, noting that for those competing in these specific bodybuilding leagues, the use of such medication would result in a “fake natty” (a slang term for a person who claims to be natural but uses banned substances) status.

Responding to accusations that he supports these medications for financial gain through his partnership with a telehealth company, Doucette maintained that his stance is based on the practical benefits for general health.

He noted that while GLP-1s are a powerful tool for weight management, they serve a different purpose than anabolic steroids or other hormone-based performance enhancers.

He emphasized that for the average person looking to improve their health and confidence, the “semantics” of bodybuilding league rules matter less than the medical results achieved under a doctor’s supervision.

The fitness veteran concluded by urging transparency in the creator community, challenging other influencers to be as open about their health data and blood work as he and certain peers have been.

Doucette has built a significant following in the fitness industry through his “natty or not” video series, where he analyzes the physiques of other celebrities and creators to guess their supplement use.

His recent focus on medical-grade weight loss tools reflects a broader shift in the creator economy toward integrating pharmaceutical healthcare and digital fitness coaching.

TAGGED:ControversyFitness
  • Social Media Trends
  • AI
  • Viral Stories
  • Controversy
  • Journalist
  • Burnout
  • Collab
  • Quitting
  • Comeback
  • Memes
  • Copyright Strike
  • Awards
  • Educator
  • Comedy
  • Events
  • Finance
  • Gaming
  • Kids Content
  • Expose
  • Mental Health
  • Travel
  • Online Courses
  • Scam
  • Tech
  • Entrepreneur
  • Strategy
  • Vlogger
  • YouTube
  • Earning

Trending Stories

Professor Of How YouTuber Launches Content Creators Cheat Codes Course

Professor Of How YouTuber Launches ‘Cheat Codes’ Course for New Content Creators

YouTube Inauthentic Content Policy policy targets low effort and repetitive videos

YouTube’s Inauthentic Content Policy Targets Low Effort AI Slop and Repetitive Videos

Super 30 Founder Anand Kumar Launches Super Infinity Digital Platform

Renowned Mathematician Anand Kumar Launches Super Infinity to Tackle Rote Learning

Jharkhand Tourism Department Launches Influencer Engagement Portal To Drive State Tourism Growth

Jharkhand Tourism Opens Official Portal For Influencer Campaign Partnerships

The Cherno Steps Down from Full-Time YouTube to Lead Robotics Startup

C++ Creator with 700K Subs Leaves Full-time YouTube to Lead Robotics Startups

Content Creators
MSK Vlogs YouTube Story

From Dharavi to Digital Fame: How MSK Built a Brand Empire Through Vlogging

Content Creators
Johnny Harris YouTube Success Story

Johnny Harris: The YouTuber Who Reinvented Global Journalism for the Internet Generation

Content Creators
MotorOctane Founder Rachit Hirani Success Story

Inspiring Story of Rachit Hirani Building MotorOctane as India’s Top Car Review Channel

Content Creators
SigmaStory Logo

SigmaStory is a digital media platform covering the creator economy, social media, and influencer life. We publish news and stories about creators, pop culture, entertainment, technology, and content creation.

Trending Topics

  • Creator Economy
  • Pop Culture
  • Influencer Life
  • Visual Stories
  • Podcast
  • Entertainment
  • Content Creators
  • Social Media
  • Memes
  • Web Series
  • OTT
  • Online Earning
  • How-to Guides

Company

  • About Us
  • Privacy Policy
  • Disclaimer
  • Contact Us

SigmaStory | All rights reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?